Skip to content
SEC filings edition: Wednesday, November 18, 2026 · 275 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Friday, November 20, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 18, 2026 0bankruptcies 5delisting notices 2late filings 33leadership changes 0IPO filings 177private raises 25earnings releases
Company page · CIK 1659073

Galvanize Therapeutics, Inc.

Filing with the SEC Private company (exempt offering) Redwood City, CA
An email when it files something new with the SEC. Your account

What this means

  • Private capital raiseOn Nov 18, 2026 the company filed Form D: $136M offered · $136M sold · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Name as filed
Galvanize Therapeutics, Inc.
CIK
0001659073
Tickers
—
Kind of filer
Private company (exempt offering)
Legal form
Corporation
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Redwood City, California
Industry (SIC)
Biotechnology (Form D industry group)
Industry: D · Manufacturing →
Last annual report
None in our data
Last quarterly report
—
Latest exempt offering
$136M offered · $136M sold
Revenue range stated: Decline to Disclose
Bankruptcy reported
Not in our data
Last edition event
Nov 18, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Private raise (Form D): $136M offered · $136M sold · Biotechnology
    Form D · items 06B · filed Nov 18, 2026 · filing · edition of Nov 18, 2026